Mitochondrial-related gene expression changes are sensitive to agonal-pH state: implications for brain disorders

Mitochondrial defects in gene expression have been implicated in the pathophysiology of bipolar disorder and schizophrenia. We have now contrasted control brains with low pH versus high pH and showed that 28% of genes in mitochondrial-related pathways meet criteria for differential expression. A maj...

Full description

Saved in:
Bibliographic Details
Published inMolecular psychiatry Vol. 11; no. 7; pp. 663 - 679
Main Authors Vawter, M P, Tomita, H, Meng, F, Bolstad, B, Li, J, Evans, S, Choudary, P, Atz, M, Shao, L, Neal, C, Walsh, D M, Burmeister, M, Speed, T, Myers, R, Jones, E G, Watson, S J, Akil, H, Bunney, W E
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 01.07.2006
Nature Publishing Group
Subjects
pH
Online AccessGet full text
ISSN1359-4184
1476-5578
DOI10.1038/sj.mp.4001830

Cover

Abstract Mitochondrial defects in gene expression have been implicated in the pathophysiology of bipolar disorder and schizophrenia. We have now contrasted control brains with low pH versus high pH and showed that 28% of genes in mitochondrial-related pathways meet criteria for differential expression. A majority of genes in the mitochondrial, chaperone and proteasome pathways of nuclear DNA-encoded gene expression were decreased with decreased brain pH, whereas a majority of genes in the apoptotic and reactive oxygen stress pathways showed an increased gene expression with a decreased brain pH. There was a significant increase in mitochondrial DNA copy number and mitochondrial DNA gene expression with increased agonal duration. To minimize effects of agonal-pH state on mood disorder comparisons, two classic approaches were used, removing all subjects with low pH and agonal factors from analysis, or grouping low and high pH as a separate variable. Three groups of potential candidate genes emerged that may be mood disorder related: (a) genes that showed no sensitivity to pH but were differentially expressed in bipolar disorder or major depressive disorder; (b) genes that were altered by agonal-pH in one direction but altered in mood disorder in the opposite direction to agonal-pH and (c) genes with agonal-pH sensitivity that displayed the same direction of changes in mood disorder. Genes from these categories such as NR4A1 and HSPA2 were confirmed with Q-PCR. The interpretation of postmortem brain studies involving broad mitochondrial gene expression and related pathway alterations must be monitored against the strong effect of agonal-pH state. Genes with the least sensitivity to agonal-pH could present a starting point for candidate gene search in neuropsychiatric disorders.
AbstractList Mitochondrial defects in gene expression have been implicated in the pathophysiology of bipolar disorder and schizophrenia. We have now contrasted control brains with low pH versus high pH and showed that 28% of genes in mitochondrial-related pathways meet criteria for differential expression. A majority of genes in the mitochondrial, chaperone and proteasome pathways of nuclear DNA-encoded gene expression were decreased with decreased brain pH, whereas a majority of genes in the apoptotic and reactive oxygen stress pathways showed an increased gene expression with a decreased brain pH. There was a significant increase in mitochondrial DNA copy number and mitochondrial DNA gene expression with increased agonal duration. To minimize effects of agonal-pH state on mood disorder comparisons, two classic approaches were used, removing all subjects with low pH and agonal factors from analysis, or grouping low and high pH as a separate variable. Three groups of potential candidate genes emerged that may be mood disorder related: (a) genes that showed no sensitivity to pH but were differentially expressed in bipolar disorder or major depressive disorder; (b) genes that were altered by agonal-pH in one direction but altered in mood disorder in the opposite direction to agonal-pH and (c) genes with agonal-pH sensitivity that displayed the same direction of changes in mood disorder. Genes from these categories such as NR4A1 and HSPA2 were confirmed with Q-PCR. The interpretation of postmortem brain studies involving broad mitochondrial gene expression and related pathway alterations must be monitored against the strong effect of agonal-pH state. Genes with the least sensitivity to agonal-pH could present a starting point for candidate gene search in neuropsychiatric disorders.
Mitochondrial defects in gene expression have been implicated in the pathophysiology of bipolar disorder and schizophrenia. We have now contrasted control brains with low pH versus high pH and showed that 28% of genes in mitochondrial-related pathways meet criteria for differential expression. A majority of genes in the mitochondrial, chaperone and proteasome pathways of nuclear DNA-encoded gene expression were decreased with decreased brain pH, whereas a majority of genes in the apoptotic and reactive oxygen stress pathways showed an increased gene expression with a decreased brain pH. There was a significant increase in mitochondrial DNA copy number and mitochondrial DNA gene expression with increased agonal duration. To minimize effects of agonal-pH state on mood disorder comparisons, two classic approaches were used, removing all subjects with low pH and agonal factors from analysis, or grouping low and high pH as a separate variable. Three groups of potential candidate genes emerged that may be mood disorder related: (a) genes that showed no sensitivity to pH but were differentially expressed in bipolar disorder or major depressive disorder; (b) genes that were altered by agonal-pH in one direction but altered in mood disorder in the opposite direction to agonal-pH and (c) genes with agonal-pH sensitivity that displayed the same direction of changes in mood disorder. Genes from these categories such as NR4A1 and HSPA2 were confirmed with Q-PCR. The interpretation of postmortem brain studies involving broad mitochondrial gene expression and related pathway alterations must be monitored against the strong effect of agonal-pH state. Genes with the least sensitivity to agonal-pH could present a starting point for candidate gene search in neuropsychiatric disorders.Molecular Psychiatry (2006) 11, 663-679. doi:10.1038/sj.mp.4001830; published online 25 April 2006
Mitochondrial defects in gene expression have been implicated in the pathophysiology of bipolar disorder and schizophrenia. We have now contrasted control brains with low pH versus high pH and showed that 28% of genes in mitochondrial-related pathways meet criteria for differential expression. A majority of genes in the mitochondrial, chaperone and proteasome pathways of nuclear DNA-encoded gene expression were decreased with decreased brain pH, whereas a majority of genes in the apoptotic and reactive oxygen stress pathways showed an increased gene expression with a decreased brain pH. There was a significant increase in mitochondrial DNA copy number and mitochondrial DNA gene expression with increased agonal duration. To minimize effects of agonal-pH state on mood disorder comparisons, two classic approaches were used, removing all subjects with low pH and agonal factors from analysis, or grouping low and high pH as a separate variable. Three groups of potential candidate genes emerged that may be mood disorder related: (a) genes that showed no sensitivity to pH but were differentially expressed in bipolar disorder or major depressive disorder; (b) genes that were altered by agonal-pH in one direction but altered in mood disorder in the opposite direction to agonal-pH and (c) genes with agonal-pH sensitivity that displayed the same direction of changes in mood disorder. Genes from these categories such as NR4A1 and HSPA2 were confirmed with Q-PCR. The interpretation of postmortem brain studies involving broad mitochondrial gene expression and related pathway alterations must be monitored against the strong effect of agonal-pH state. Genes with the least sensitivity to agonal-pH could present a starting point for candidate gene search in neuropsychiatric disorders.Mitochondrial defects in gene expression have been implicated in the pathophysiology of bipolar disorder and schizophrenia. We have now contrasted control brains with low pH versus high pH and showed that 28% of genes in mitochondrial-related pathways meet criteria for differential expression. A majority of genes in the mitochondrial, chaperone and proteasome pathways of nuclear DNA-encoded gene expression were decreased with decreased brain pH, whereas a majority of genes in the apoptotic and reactive oxygen stress pathways showed an increased gene expression with a decreased brain pH. There was a significant increase in mitochondrial DNA copy number and mitochondrial DNA gene expression with increased agonal duration. To minimize effects of agonal-pH state on mood disorder comparisons, two classic approaches were used, removing all subjects with low pH and agonal factors from analysis, or grouping low and high pH as a separate variable. Three groups of potential candidate genes emerged that may be mood disorder related: (a) genes that showed no sensitivity to pH but were differentially expressed in bipolar disorder or major depressive disorder; (b) genes that were altered by agonal-pH in one direction but altered in mood disorder in the opposite direction to agonal-pH and (c) genes with agonal-pH sensitivity that displayed the same direction of changes in mood disorder. Genes from these categories such as NR4A1 and HSPA2 were confirmed with Q-PCR. The interpretation of postmortem brain studies involving broad mitochondrial gene expression and related pathway alterations must be monitored against the strong effect of agonal-pH state. Genes with the least sensitivity to agonal-pH could present a starting point for candidate gene search in neuropsychiatric disorders.
Audience Academic
Author Akil, H
Walsh, D M
Neal, C
Myers, R
Li, J
Tomita, H
Burmeister, M
Speed, T
Vawter, M P
Shao, L
Evans, S
Choudary, P
Bolstad, B
Meng, F
Atz, M
Jones, E G
Bunney, W E
Watson, S J
AuthorAffiliation 3 Biostatistics, University of California, Berkeley, CA, USA
2 Mental Health Research Institute, University of Michigan, Ann Arbor, MI, USA
1 Department of Psychiatry, University of California, Irvine, CA, USA
4 Stanford Human Genome Center, Stanford University, Palo Alto, CA, USA
6 University of Hawaii, John A. Burns School of Medicine, Honolulu, HI, USA
5 Center for Neuroscience, University of California, Davis, CA, USA
AuthorAffiliation_xml – name: 2 Mental Health Research Institute, University of Michigan, Ann Arbor, MI, USA
– name: 3 Biostatistics, University of California, Berkeley, CA, USA
– name: 1 Department of Psychiatry, University of California, Irvine, CA, USA
– name: 4 Stanford Human Genome Center, Stanford University, Palo Alto, CA, USA
– name: 5 Center for Neuroscience, University of California, Davis, CA, USA
– name: 6 University of Hawaii, John A. Burns School of Medicine, Honolulu, HI, USA
Author_xml – sequence: 1
  givenname: M P
  surname: Vawter
  fullname: Vawter, M P
  email: mvawter@uci.edu
  organization: Department of Psychiatry, University of California
– sequence: 2
  givenname: H
  surname: Tomita
  fullname: Tomita, H
  organization: Department of Psychiatry, University of California
– sequence: 3
  givenname: F
  surname: Meng
  fullname: Meng, F
  organization: Mental Health Research Institute, University of Michigan
– sequence: 4
  givenname: B
  surname: Bolstad
  fullname: Bolstad, B
  organization: Biostatistics, University of California
– sequence: 5
  givenname: J
  surname: Li
  fullname: Li, J
  organization: Stanford Human Genome Center, Stanford University
– sequence: 6
  givenname: S
  surname: Evans
  fullname: Evans, S
  organization: Mental Health Research Institute, University of Michigan
– sequence: 7
  givenname: P
  surname: Choudary
  fullname: Choudary, P
  organization: Center for Neuroscience, University of California
– sequence: 8
  givenname: M
  surname: Atz
  fullname: Atz, M
  organization: Department of Psychiatry, University of California
– sequence: 9
  givenname: L
  surname: Shao
  fullname: Shao, L
  organization: Department of Psychiatry, University of California
– sequence: 10
  givenname: C
  surname: Neal
  fullname: Neal, C
  organization: University of Hawaii, John A. Burns School of Medicine
– sequence: 11
  givenname: D M
  surname: Walsh
  fullname: Walsh, D M
  organization: Department of Psychiatry, University of California
– sequence: 12
  givenname: M
  surname: Burmeister
  fullname: Burmeister, M
  organization: Mental Health Research Institute, University of Michigan
– sequence: 13
  givenname: T
  surname: Speed
  fullname: Speed, T
  organization: Biostatistics, University of California
– sequence: 14
  givenname: R
  surname: Myers
  fullname: Myers, R
  organization: Stanford Human Genome Center, Stanford University
– sequence: 15
  givenname: E G
  surname: Jones
  fullname: Jones, E G
  organization: Center for Neuroscience, University of California
– sequence: 16
  givenname: S J
  surname: Watson
  fullname: Watson, S J
  organization: Mental Health Research Institute, University of Michigan
– sequence: 17
  givenname: H
  surname: Akil
  fullname: Akil, H
  organization: Mental Health Research Institute, University of Michigan
– sequence: 18
  givenname: W E
  surname: Bunney
  fullname: Bunney, W E
  organization: Department of Psychiatry, University of California
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=17936369$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/16636682$$D View this record in MEDLINE/PubMed
BookMark eNp9ks1v1DAQxSNURD_gyBVZIOCUJU78yQGpqoAiFXGBs-U4k12vEjvY2Yr-952lC0urFvlgy_N7z57ROy4OQgxQFM9ptaBVo97l9WKcFqyqqGqqR8URZVKUnEt1gOeG65JRxQ6L45zXyGCRPykOqRCNEKo-Kqavfo5uFUOXvB3KBIOdoSNLCEDg15QgZx8DcSsblpCJTUAyhOxnfwlkjsQuY0DddE7yjMr3xI_T4J2dUZVJHxNpk_WBdD7H1EHKT4vHvR0yPNvtJ8WPTx-_n52XF98-fzk7vSidaPhcgnSiqzqmOias67S0ddV2nEmlGHNOV5ZLK3tBWaN0DUBpzUUr29bKugVeNyfFhxvfadOO0DkIc7KDmZIfbboy0XpzuxL8yizjpWkqrThXaPB2Z5Dizw3k2Yw-OxgGGyBuspFcN1RxKZF8819SIKWVFgi-ugOu4ybh_LKpBeOS11Rt7V4-SNXYJlOc7q2WdgDjQx-xCbd915xSpTgTmldILe6hcHUweodB6j3e3xK8-Hdqf8f1JzAIvN4BNjs79MkG5_Oek7pBUiNX3nAuxZwT9HukMtvgmrw242R2wUW-ucM7P_9OEf7YDw-qdv1ldMeApv2o7hdcA5CNANs
CitedBy_id crossref_primary_10_1016_j_neubiorev_2022_104892
crossref_primary_10_1016_j_biopsych_2007_11_010
crossref_primary_10_1016_j_biopsych_2008_11_010
crossref_primary_10_1371_journal_pone_0190456
crossref_primary_10_1007_s12640_016_9621_9
crossref_primary_10_1016_j_schres_2014_08_026
crossref_primary_10_1038_s41398_017_0048_8
crossref_primary_10_1016_j_brainresbull_2011_07_018
crossref_primary_10_1002_pmic_200900287
crossref_primary_10_3390_biomedicines9050522
crossref_primary_10_1016_j_schres_2020_09_003
crossref_primary_10_1016_j_bbi_2021_09_003
crossref_primary_10_1196_annals_1432_027
crossref_primary_10_1186_1755_8794_2_62
crossref_primary_10_1016_j_biopsych_2017_09_010
crossref_primary_10_1016_j_ceca_2007_11_005
crossref_primary_10_1016_j_pnpbp_2013_09_002
crossref_primary_10_1038_sj_mp_4001969
crossref_primary_10_1038_mp_2009_18
crossref_primary_10_1038_tp_2016_224
crossref_primary_10_1016_j_brainres_2010_01_006
crossref_primary_10_1111_j_1440_1819_2010_02178_x
crossref_primary_10_1038_mp_2016_65
crossref_primary_10_1007_s00401_011_0828_9
crossref_primary_10_1016_j_schres_2011_06_024
crossref_primary_10_1371_journal_pone_0053855
crossref_primary_10_1038_sj_mp_4002095
crossref_primary_10_1038_sj_npp_1301671
crossref_primary_10_1002_ajmg_b_32134
crossref_primary_10_1016_j_ncl_2015_08_011
crossref_primary_10_1111_j_1399_5618_2008_00607_x
crossref_primary_10_1016_j_ajp_2020_102193
crossref_primary_10_1038_mp_2009_117
crossref_primary_10_1016_j_pnpbp_2015_06_012
crossref_primary_10_7554_eLife_89376
crossref_primary_10_1016_j_nbd_2011_03_001
crossref_primary_10_1155_2014_452891
crossref_primary_10_1016_j_biopsych_2009_12_011
crossref_primary_10_1016_j_neures_2008_12_004
crossref_primary_10_1002_ajmg_b_30481
crossref_primary_10_1080_07853890801923753
crossref_primary_10_1016_j_psychres_2024_115928
crossref_primary_10_1016_j_nbd_2010_11_004
crossref_primary_10_1016_j_neuropharm_2011_07_023
crossref_primary_10_1111_j_1365_2990_2012_01285_x
crossref_primary_10_1038_jhg_2009_93
crossref_primary_10_1038_mp_2014_157
crossref_primary_10_1038_sj_mp_4001875
crossref_primary_10_1016_j_neubiorev_2017_01_014
crossref_primary_10_1038_npp_2013_239
crossref_primary_10_1136_jech_2013_202430
crossref_primary_10_1016_j_biopsych_2010_09_035
crossref_primary_10_1016_j_neubiorev_2016_06_040
crossref_primary_10_1371_journal_pone_0049183
crossref_primary_10_1002_ajmg_b_30707
crossref_primary_10_1038_tp_2014_9
crossref_primary_10_1016_j_jneumeth_2007_03_022
crossref_primary_10_7554_eLife_89376_3
crossref_primary_10_1007_s11011_013_9473_4
crossref_primary_10_1016_j_csbj_2022_08_037
crossref_primary_10_1016_j_jpsychires_2023_01_005
crossref_primary_10_7554_eLife_31126
crossref_primary_10_1016_j_euroneuro_2024_10_012
crossref_primary_10_1007_s00702_009_0319_5
crossref_primary_10_1016_j_neurobiolaging_2011_04_010
crossref_primary_10_1016_j_biopsych_2014_12_025
crossref_primary_10_1016_j_jpsychires_2020_11_016
crossref_primary_10_1016_j_pbb_2011_01_017
crossref_primary_10_1038_s41537_019_0089_5
crossref_primary_10_1002_cne_24543
crossref_primary_10_3390_ijms22168358
crossref_primary_10_1038_mp_2014_63
crossref_primary_10_1111_pcn_12163
crossref_primary_10_1186_2045_5380_2_10
crossref_primary_10_1038_s41598_017_03599_8
crossref_primary_10_1002_pmic_200900015
crossref_primary_10_1007_s00702_006_0581_8
crossref_primary_10_1155_2015_408136
crossref_primary_10_3109_00048670903393662
crossref_primary_10_1016_j_nbd_2011_01_025
crossref_primary_10_1016_j_biopsych_2011_03_038
crossref_primary_10_1007_s00401_009_0482_7
crossref_primary_10_1080_15622975_2020_1755450
crossref_primary_10_1177_070674370705201203
crossref_primary_10_1016_j_pneurobio_2009_09_001
crossref_primary_10_1016_j_tins_2008_07_007
crossref_primary_10_1016_j_mcn_2020_103555
crossref_primary_10_1016_j_schres_2022_08_027
crossref_primary_10_1016_j_jpsychires_2015_10_015
crossref_primary_10_1089_omi_2006_10_444
Cites_doi 10.1001/archpsyc.61.5.450
10.1007/BF01251916
10.1016/j.biopsych.2003.10.016
10.1046/j.1365-2141.2003.04601.x
10.1001/archpsyc.61.3.300
10.1073/pnas.0406788101
10.1002/jnr.10631
10.1016/S0197-4580(99)00092-5
10.1016/0041-008X(88)90031-2
10.1016/S0891-0618(01)00135-1
10.1146/annurev.bi.65.070196.003023
10.1038/nm972
10.1034/j.1399-5618.2000.020305.x
10.1038/sj.mp.4001511
10.1016/j.biopsych.2005.03.031
10.1038/sj.npp.1300400
10.1073/pnas.0630589100
10.2144/04364ST03
10.1016/S0361-9230(01)00744-4
10.1016/S0920-9964(01)00377-2
10.1016/S0006-3223(03)00114-8
10.1111/j.1471-4159.2004.02570.x
10.1074/jbc.M106583200
10.1016/S0006-3223(97)00012-7
10.1073/pnas.95.22.13290
10.1016/0006-2952(86)90108-5
10.1016/S0165-0270(97)00115-5
10.1016/S0006-3223(00)00988-4
10.1016/j.molbrainres.2004.09.010
10.1186/gb-2003-4-10-r70
10.1038/ng1291
10.1586/14737159.3.5.635
10.1038/sj.npp.1300335
10.1016/j.jneumeth.2004.04.002
10.1038/sj.npp.1300337
10.1001/archpsyc.58.6.545
10.1002/(SICI)1096-8628(20000403)96:2<182::AID-AJMG12>3.0.CO;2-Q
10.1007/s004010100392
10.1093/nar/gni179
10.1007/BF02834269
10.1111/j.1399-5618.2005.00184.x
10.1002/ajmg.b.20041
10.1073/pnas.081071198
10.1016/j.biopsych.2003.10.013
10.1073/pnas.0403649101
10.1016/0165-0327(93)90097-4
10.1176/ajp.154.7.976
10.1101/gr.1982804
10.1016/S0006-291X(03)00473-X
10.1046/j.1471-4159.2002.01263.x
10.1016/S0006-3223(99)00041-4
10.1023/B:NERE.0000023611.99452.47
10.1042/BJ20040469
10.1016/S0165-0327(99)00173-1
10.1016/S0304-3940(02)01334-4
10.1038/sj.mp.4001758
10.1111/j.1440-1819.2004.01197.x
10.1523/JNEUROSCI.22-07-02718.2002
10.1016/S0361-9230(01)00522-6
10.1074/jbc.M006807200
10.1073/pnas.242716699
10.1002/cne.903590310
10.1016/0165-0327(95)00050-X
10.1038/sj.mp.4001565
10.1023/A:1006912010550
10.1016/S0022-3476(87)80157-9
10.1038/ng1235
10.1093/brain/awf149
10.1016/j.biopsych.2004.11.041
10.1093/cercor/12.4.386
10.1016/S0006-3223(00)00978-1
10.1093/hmg/ddi022
10.1038/sj.mp.4001437
10.1097/01.ASN.0000095481.24091.C9
10.1016/0925-4927(94)90010-8
10.1046/j.1471-4159.2001.00628.x
10.1093/hmg/ddh065
10.1016/0304-3940(95)12102-A
10.1186/gb-2003-4-5-p3
10.1034/j.1399-5618.2002.40201.x
ContentType Journal Article
Copyright Springer Nature Limited 2006
2006 INIST-CNRS
COPYRIGHT 2006 Nature Publishing Group
Copyright Nature Publishing Group Jul 2006
Nature Publishing Group 2006.
2006 Nature Publishing Group All rights reserved 2006
Copyright_xml – notice: Springer Nature Limited 2006
– notice: 2006 INIST-CNRS
– notice: COPYRIGHT 2006 Nature Publishing Group
– notice: Copyright Nature Publishing Group Jul 2006
– notice: Nature Publishing Group 2006.
– notice: 2006 Nature Publishing Group All rights reserved 2006
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7TK
7X7
7XB
88E
88G
8AO
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M1P
M2M
M7P
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
PSYQQ
Q9U
7X8
5PM
DOI 10.1038/sj.mp.4001830
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Neurosciences Abstracts
ProQuest Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Psychology Database (Alumni)
ProQuest Pharma Collection
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Biological Science Collection
Health & Medical Collection (Alumni)
Medical Database
Psychology Collection
Biological Science Database
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest One Psychology
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest One Psychology
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central China
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Psychology Journals (Alumni)
Biological Science Database
ProQuest SciTech Collection
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest Psychology Journals
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList ProQuest One Psychology
Neurosciences Abstracts

ProQuest One Psychology

MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Biology
EISSN 1476-5578
EndPage 679
ExternalDocumentID PMC3098558
1067213431
A188546950
16636682
17936369
10_1038_sj_mp_4001830
Genre Comparative Study
Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NIMH NIH HHS
  grantid: P50 MH60398
– fundername: NIMH NIH HHS
  grantid: P01 MH042251
– fundername: NIMH NIH HHS
  grantid: MH54844
– fundername: NIMH NIH HHS
  grantid: P50 MH060398
– fundername: NIMH NIH HHS
  grantid: R01 MH054844
– fundername: NIMH NIH HHS
  grantid: MH42251
GroupedDBID ---
-Q-
0R~
123
29M
2WC
36B
39C
4.4
406
53G
7X7
88E
8AO
8FI
8FJ
8R4
8R5
AANZL
AASML
AAYZH
ABAKF
ABAWZ
ABBRH
ABDBE
ABDBF
ABFSG
ABIVO
ABJNI
ABLJU
ABRTQ
ABUWG
ABZZP
ACAOD
ACGFS
ACKTT
ACPRK
ACRQY
ACSTC
ACUHS
ACZOJ
ADBBV
AEFQL
AEJRE
AEMSY
AENEX
AEVLU
AEXYK
AEZWR
AFBBN
AFDZB
AFHIU
AFKRA
AFRAH
AFSHS
AGAYW
AGHAI
AGQEE
AHMBA
AHSBF
AHWEU
AIGIU
AILAN
AIXLP
AJRNO
ALFFA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMYLF
ATHPR
AXYYD
AYFIA
AZQEC
B0M
BBNVY
BENPR
BHPHI
BKKNO
BPHCQ
BVXVI
CAG
CCPQU
COF
CS3
DIK
DNIVK
DPUIP
DU5
DWQXO
E3Z
EAD
EAP
EBC
EBD
EBLON
EBS
EE.
EIOEI
EJD
EMB
EMK
EMOBN
EPL
EPS
ESX
F5P
FDQFY
FEDTE
FERAY
FIZPM
FSGXE
FYUFA
GNUQQ
HCIFZ
HMCUK
HVGLF
HZ~
IAO
IHR
INH
INR
IPY
ITC
IWAJR
JSO
JZLTJ
KQ8
M1P
M2M
M7P
NQJWS
O9-
OK1
OVD
P2P
PHGZM
PHGZT
PJZUB
PPXIY
PQGLB
PQQKQ
PROAC
PSQYO
PSYQQ
Q2X
RNS
RNT
RNTTT
ROL
SNX
SNYQT
SOHCF
SOJ
SRMVM
SV3
SWTZT
TAOOD
TBHMF
TDRGL
TEORI
TR2
TSG
TUS
UKHRP
~8M
AAYXX
CITATION
70F
AACDK
AATNV
BAWUL
FIGPU
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
PMFND
AEIIB
3V.
7TK
7XB
8FE
8FH
8FK
K9.
LK8
PKEHL
PQEST
PQUKI
PRINS
Q9U
7X8
PUEGO
5PM
ID FETCH-LOGICAL-c635t-e7c6d0d48d46acd97a20bd5478844cc90a57a7f6143892ee11256b7bba72be523
IEDL.DBID 7X7
ISSN 1359-4184
IngestDate Thu Aug 21 18:21:15 EDT 2025
Fri Sep 05 05:30:18 EDT 2025
Thu Sep 04 22:17:22 EDT 2025
Fri Jul 25 08:45:38 EDT 2025
Fri Jul 25 09:11:37 EDT 2025
Tue Jun 17 22:22:17 EDT 2025
Tue Jun 10 21:15:04 EDT 2025
Fri May 30 11:00:56 EDT 2025
Wed Apr 02 07:24:00 EDT 2025
Thu Apr 24 22:51:19 EDT 2025
Tue Jul 01 00:21:36 EDT 2025
Mon Jul 21 06:09:52 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 7
Keywords proteasome
apoptosis
recurrent major depressive disorder
chaperone
bipolar disorder I
mitochondria
Mood disorder
Human
Multicatalytic endopeptidase complex
Relapse
Enzyme
Central nervous system
Depression
Bipolar disorder
Gene expression
Encephalon
Peptidases
Mitochondria
pH
Hydrolases
Apoptosis
Language English
License CC BY 4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c635t-e7c6d0d48d46acd97a20bd5478844cc90a57a7f6143892ee11256b7bba72be523
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 14
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
PMID 16636682
PQID 221254851
PQPubID 44096
PageCount 17
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_3098558
proquest_miscellaneous_759318577
proquest_miscellaneous_68579896
proquest_journals_2645752187
proquest_journals_221254851
gale_infotracmisc_A188546950
gale_infotracacademiconefile_A188546950
pubmed_primary_16636682
pascalfrancis_primary_17936369
crossref_primary_10_1038_sj_mp_4001830
crossref_citationtrail_10_1038_sj_mp_4001830
springer_journals_10_1038_sj_mp_4001830
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2006-07-01
PublicationDateYYYYMMDD 2006-07-01
PublicationDate_xml – month: 07
  year: 2006
  text: 2006-07-01
  day: 01
PublicationDecade 2000
PublicationPlace London
PublicationPlace_xml – name: London
– name: Basingstoke
– name: England
– name: New York
PublicationTitle Molecular psychiatry
PublicationTitleAbbrev Mol Psychiatry
PublicationTitleAlternate Mol Psychiatry
PublicationYear 2006
Publisher Nature Publishing Group UK
Nature Publishing Group
Publisher_xml – name: Nature Publishing Group UK
– name: Nature Publishing Group
References S Melov (BF4001830_CR63) 1999; 20
J Liu (BF4001830_CR87) 2004; 90
RO Poyton (BF4001830_CR48) 1996; 65
A Rotig (BF4001830_CR49) 2003; 14
T Kato (BF4001830_CR58) 1996; 37
MP Vawter (BF4001830_CR46) 2000; 48
M Emamghoreishi (BF4001830_CR56) 1997; 154
TL Petryshen (BF4001830_CR6) 2003
A Traven (BF4001830_CR47) 2001; 276
CA Altar (BF4001830_CR14) 2005; 58
MP Vawter (BF4001830_CR20) 2002; 58
A Sequeira (BF4001830_CR7) 2003
SR Dager (BF4001830_CR54) 2004; 61
T Kato (BF4001830_CR59) 1997; 42
NL Johnston (BF4001830_CR28) 1997; 77
MP Vawter (BF4001830_CR42) 2004; 29
S Washizuka (BF4001830_CR68) 2005; 7
SA McCarroll (BF4001830_CR69) 2004; 36
D Cotter (BF4001830_CR74) 2001; 58
MM Ryan (BF4001830_CR34) 2004; 55
C Curti (BF4001830_CR80) 1999; 199
NA Gray (BF4001830_CR39) 2003; 64
AM Roberton (BF4001830_CR82) 1988; 93
JK Kane (BF4001830_CR85) 2004; 132
G Chana (BF4001830_CR78) 2003; 53
S Washizuka (BF4001830_CR67) 2003; 120B
H Hamakawa (BF4001830_CR51) 2004; 58
DA Hosack (BF4001830_CR40) 2003; 4
T Kato (BF4001830_CR52) 1994; 55
D Ben-Shachar (BF4001830_CR88) 2002; 83
T Kato (BF4001830_CR60) 2000; 96
X Li (BF4001830_CR72) 2002; 4
K Eto (BF4001830_CR81) 1985; 39
MJ Wasserman (BF4001830_CR55) 2004; 29
K Iwamoto (BF4001830_CR22) 2004; 9
K Brodmann (BF4001830_CR31) 1909
C Bouras (BF4001830_CR75) 2001; 102
C Aston (BF4001830_CR4) 2005; 10
HK Manji (BF4001830_CR38) 2001; 35
MP Vawter (BF4001830_CR21) 2001; 55
F Xu (BF4001830_CR45) 2004; 382
ND Trinklein (BF4001830_CR70) 2004; 14
C Morin (BF4001830_CR50) 1993; 53
PJ Harrison (BF4001830_CR35) 1995; 200
E Sibille (BF4001830_CR9) 2004; 29
MP Vawter (BF4001830_CR33) 2004; 29
BH Robinson (BF4001830_CR25) 1987; 110
JA Hardy (BF4001830_CR27) 1985; 61
S Prabakaran (BF4001830_CR16) 2004; 9
SJ Huffaker (BF4001830_CR5) 2003
LF Jarskog (BF4001830_CR71) 2000; 48
JZ Li (BF4001830_CR26) 2004; 13
EC Weinbach (BF4001830_CR79) 1986; 35
G Dennis Jr (BF4001830_CR41) 2003; 4
CR Neal Jr (BF4001830_CR43) 2001; 22
G Rajkowska (BF4001830_CR77) 1999; 45
CD Chen (BF4001830_CR3) 2004; 10
P Wester (BF4001830_CR29) 1985; 3
L Dyrskjot (BF4001830_CR1) 2003; 3
C Konradi (BF4001830_CR11) 2004; 61
YB Bezchlibnyk (BF4001830_CR8) 2001; 79
FM Benes (BF4001830_CR44) 2006; 11
C Kakiuchi (BF4001830_CR66) 2003; 35
T Kato (BF4001830_CR65) 2003; 338
PE Coskun (BF4001830_CR61) 2003; 100
KM Holtz (BF4001830_CR83) 2003; 303
Y Hakak (BF4001830_CR19) 2001; 98
K Munakata (BF4001830_CR57) 2005; 57
D Cotter (BF4001830_CR73) 2002; 12
LW Jurata (BF4001830_CR12) 2004; 138
SJ Evans (BF4001830_CR13) 2004; 101
M Dai (BF4001830_CR37) 2005; 33
PJ Harrison (BF4001830_CR15) 2002; 125
FA Middleton (BF4001830_CR17) 2002; 22
T Kato (BF4001830_CR23) 2000; 2
K Iwamoto (BF4001830_CR10) 2005; 14
AM Rice (BF4001830_CR84) 2001; 276
BP Sokolov (BF4001830_CR18) 2003; 72
T Kato (BF4001830_CR64) 2001; 62
F Bosetti (BF4001830_CR86) 2002; 57
M Ueda (BF4001830_CR2) 2003; 123
PE Coskun (BF4001830_CR62) 2004; 101
BA Vogt (BF4001830_CR32) 1995; 359
D Ongur (BF4001830_CR76) 1998; 95
H Tomita (BF4001830_CR30) 2004; 55
T Kato (BF4001830_CR53) 1993; 27
VK Mootha (BF4001830_CR24) 2003; 100
CL Miller (BF4001830_CR36) 2004; 36
References_xml – volume: 61
  start-page: 450
  issue: 5
  year: 2004
  ident: BF4001830_CR54
  publication-title: Arch Gen Psychiatry
  doi: 10.1001/archpsyc.61.5.450
– volume: 61
  start-page: 253
  issue: 3–4
  year: 1985
  ident: BF4001830_CR27
  publication-title: J Neural Transm
  doi: 10.1007/BF01251916
– volume: 55
  start-page: 329
  issue: 4
  year: 2004
  ident: BF4001830_CR34
  publication-title: Biol Psychiatry
  doi: 10.1016/j.biopsych.2003.10.016
– volume: 123
  start-page: 288
  issue: 2
  year: 2003
  ident: BF4001830_CR2
  publication-title: Br J Haematol
  doi: 10.1046/j.1365-2141.2003.04601.x
– volume: 61
  start-page: 300
  issue: 3
  year: 2004
  ident: BF4001830_CR11
  publication-title: Arch Gen Psychiatry
  doi: 10.1001/archpsyc.61.3.300
– volume: 101
  start-page: 15506
  issue: 43
  year: 2004
  ident: BF4001830_CR13
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.0406788101
– volume-title: Identification of altered gene pathways in prefrontal cortex and cerebellum of schizophrenia, bipolar disorder, and depression patients. Program Number 312.12, in Abstract Viewer/Itinerary Planner
  year: 2003
  ident: BF4001830_CR6
– volume: 72
  start-page: 756
  issue: 6
  year: 2003
  ident: BF4001830_CR18
  publication-title: J Neurosci Res
  doi: 10.1002/jnr.10631
– volume: 20
  start-page: 565
  issue: 5
  year: 1999
  ident: BF4001830_CR63
  publication-title: Neurobiol Aging
  doi: 10.1016/S0197-4580(99)00092-5
– volume: 93
  start-page: 118
  issue: 1
  year: 1988
  ident: BF4001830_CR82
  publication-title: Toxicol Appl Pharmacol
  doi: 10.1016/0041-008X(88)90031-2
– volume: 22
  start-page: 219
  issue: 4
  year: 2001
  ident: BF4001830_CR43
  publication-title: J Chem Neuroanat
  doi: 10.1016/S0891-0618(01)00135-1
– volume: 65
  start-page: 563
  year: 1996
  ident: BF4001830_CR48
  publication-title: Annu Rev Biochem
  doi: 10.1146/annurev.bi.65.070196.003023
– volume: 10
  start-page: 33
  issue: 1
  year: 2004
  ident: BF4001830_CR3
  publication-title: Nat Med
  doi: 10.1038/nm972
– volume: 2
  start-page: 180
  issue: 3 Part 1
  year: 2000
  ident: BF4001830_CR23
  publication-title: Bipolar Disord
  doi: 10.1034/j.1399-5618.2000.020305.x
– volume: 9
  start-page: 684
  issue: 7
  year: 2004
  ident: BF4001830_CR16
  publication-title: Mol Psychiatry
  doi: 10.1038/sj.mp.4001511
– volume-title: Gene expression changes in suicides with and without major depression. Program Number 640.2, in Abstract Viewer/ Itinerary Planner
  year: 2003
  ident: BF4001830_CR7
– volume: 64
  start-page: 3
  issue: Suppl 5
  year: 2003
  ident: BF4001830_CR39
  publication-title: J Clin Psychiatry
– volume: 58
  start-page: 85
  issue: 2
  year: 2005
  ident: BF4001830_CR14
  publication-title: Biol Psychiatry
  doi: 10.1016/j.biopsych.2005.03.031
– volume: 29
  start-page: 759
  issue: 4
  year: 2004
  ident: BF4001830_CR55
  publication-title: Neuropsychopharmacology
  doi: 10.1038/sj.npp.1300400
– volume: 100
  start-page: 2174
  issue: 5
  year: 2003
  ident: BF4001830_CR61
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.0630589100
– volume: 36
  start-page: 628
  issue: 4
  year: 2004
  ident: BF4001830_CR36
  publication-title: Biotechniques
  doi: 10.2144/04364ST03
– volume: 57
  start-page: 205
  issue: 2
  year: 2002
  ident: BF4001830_CR86
  publication-title: Brain Res Bull
  doi: 10.1016/S0361-9230(01)00744-4
– volume: 58
  start-page: 11
  issue: 1
  year: 2002
  ident: BF4001830_CR20
  publication-title: Schizophr Res
  doi: 10.1016/S0920-9964(01)00377-2
– volume: 53
  start-page: 1086
  issue: 12
  year: 2003
  ident: BF4001830_CR78
  publication-title: Biol Psychiatry
  doi: 10.1016/S0006-3223(03)00114-8
– volume: 90
  start-page: 1050
  issue: 5
  year: 2004
  ident: BF4001830_CR87
  publication-title: J Neurochem
  doi: 10.1111/j.1471-4159.2004.02570.x
– volume: 35
  start-page: 5
  issue: 2
  year: 2001
  ident: BF4001830_CR38
  publication-title: Psychopharmacol Bull
– volume: 276
  start-page: 42722
  issue: 46
  year: 2001
  ident: BF4001830_CR84
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M106583200
– volume: 42
  start-page: 871
  issue: 10
  year: 1997
  ident: BF4001830_CR59
  publication-title: Biol Psychiatry
  doi: 10.1016/S0006-3223(97)00012-7
– volume: 95
  start-page: 13290
  issue: 22
  year: 1998
  ident: BF4001830_CR76
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.95.22.13290
– volume: 35
  start-page: 1445
  issue: 9
  year: 1986
  ident: BF4001830_CR79
  publication-title: Biochem Pharmacol
  doi: 10.1016/0006-2952(86)90108-5
– volume: 53
  start-page: 488
  issue: 2
  year: 1993
  ident: BF4001830_CR50
  publication-title: Am J Hum Genet
– volume: 77
  start-page: 83
  issue: 1
  year: 1997
  ident: BF4001830_CR28
  publication-title: J Neurosci Methods
  doi: 10.1016/S0165-0270(97)00115-5
– volume: 48
  start-page: 641
  issue: 7
  year: 2000
  ident: BF4001830_CR71
  publication-title: Biol Psychiatry
  doi: 10.1016/S0006-3223(00)00988-4
– volume: 132
  start-page: 181
  issue: 2
  year: 2004
  ident: BF4001830_CR85
  publication-title: Brain Res Mol Brain Res
  doi: 10.1016/j.molbrainres.2004.09.010
– volume: 4
  start-page: R70
  issue: 10
  year: 2003
  ident: BF4001830_CR40
  publication-title: Genome Biol
  doi: 10.1186/gb-2003-4-10-r70
– volume: 36
  start-page: 197
  issue: 2
  year: 2004
  ident: BF4001830_CR69
  publication-title: Nat Genet
  doi: 10.1038/ng1291
– volume: 3
  start-page: 635
  issue: 5
  year: 2003
  ident: BF4001830_CR1
  publication-title: Expert Rev Mol Diagn
  doi: 10.1586/14737159.3.5.635
– volume: 29
  start-page: 351
  issue: 2
  year: 2004
  ident: BF4001830_CR9
  publication-title: Neuropsychopharmacology
  doi: 10.1038/sj.npp.1300335
– volume: 138
  start-page: 173
  issue: 1–2
  year: 2004
  ident: BF4001830_CR12
  publication-title: J Neurosci Methods
  doi: 10.1016/j.jneumeth.2004.04.002
– volume: 29
  start-page: 373
  issue: 2
  year: 2004
  ident: BF4001830_CR33
  publication-title: Neuropsychopharmacology
  doi: 10.1038/sj.npp.1300337
– volume: 58
  start-page: 545
  issue: 6
  year: 2001
  ident: BF4001830_CR74
  publication-title: Arch Gen Psychiatry
  doi: 10.1001/archpsyc.58.6.545
– volume: 96
  start-page: 182
  issue: 2
  year: 2000
  ident: BF4001830_CR60
  publication-title: Am J Med Genet
  doi: 10.1002/(SICI)1096-8628(20000403)96:2<182::AID-AJMG12>3.0.CO;2-Q
– volume: 102
  start-page: 373
  issue: 4
  year: 2001
  ident: BF4001830_CR75
  publication-title: Acta Neuropathol (Berlin)
  doi: 10.1007/s004010100392
– volume: 33
  start-page: e175
  issue: 20
  year: 2005
  ident: BF4001830_CR37
  publication-title: Nucleic Acids Res
  doi: 10.1093/nar/gni179
– volume: 3
  start-page: 169
  issue: 3
  year: 1985
  ident: BF4001830_CR29
  publication-title: Neurochem Pathol
  doi: 10.1007/BF02834269
– volume: 7
  start-page: 146
  issue: 2
  year: 2005
  ident: BF4001830_CR68
  publication-title: Bipolar Disord
  doi: 10.1111/j.1399-5618.2005.00184.x
– volume-title: Vergleichende Lokalisationslehre der Grosshirnrinde in ihren Prinzipien dargestellt auf Grund des Zellenbaues
  year: 1909
  ident: BF4001830_CR31
– volume: 120B
  start-page: 72
  issue: 1
  year: 2003
  ident: BF4001830_CR67
  publication-title: Am J Med Genet
  doi: 10.1002/ajmg.b.20041
– volume: 98
  start-page: 4746
  issue: 8
  year: 2001
  ident: BF4001830_CR19
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.081071198
– volume: 55
  start-page: 346
  issue: 4
  year: 2004
  ident: BF4001830_CR30
  publication-title: Biol Psychiatry
  doi: 10.1016/j.biopsych.2003.10.013
– volume: 39
  start-page: 289
  issue: 4
  year: 1985
  ident: BF4001830_CR81
  publication-title: Acta Med Okayama
– volume: 101
  start-page: 10726
  issue: 29
  year: 2004
  ident: BF4001830_CR62
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.0403649101
– volume: 27
  start-page: 53
  issue: 1
  year: 1993
  ident: BF4001830_CR53
  publication-title: J Affect Disord
  doi: 10.1016/0165-0327(93)90097-4
– volume: 154
  start-page: 976
  issue: 7
  year: 1997
  ident: BF4001830_CR56
  publication-title: Am J Psychiatry
  doi: 10.1176/ajp.154.7.976
– volume: 14
  start-page: 62
  issue: 1
  year: 2004
  ident: BF4001830_CR70
  publication-title: Genome Res
  doi: 10.1101/gr.1982804
– volume: 303
  start-page: 1058
  issue: 4
  year: 2003
  ident: BF4001830_CR83
  publication-title: Biochem Biophys Res Commun
  doi: 10.1016/S0006-291X(03)00473-X
– volume: 83
  start-page: 1241
  issue: 6
  year: 2002
  ident: BF4001830_CR88
  publication-title: J Neurochem
  doi: 10.1046/j.1471-4159.2002.01263.x
– volume: 45
  start-page: 1085
  issue: 9
  year: 1999
  ident: BF4001830_CR77
  publication-title: Biol Psychiatry
  doi: 10.1016/S0006-3223(99)00041-4
– volume-title: Large scale genechip analysis of post - mortem brains from schizophrenia and bipolar affective disorder patients. Program Number 312.16, in Abstract Viewer/ Itinerary Planner
  year: 2003
  ident: BF4001830_CR5
– volume: 29
  start-page: 1245
  issue: 6
  year: 2004
  ident: BF4001830_CR42
  publication-title: Neurochem Res
  doi: 10.1023/B:NERE.0000023611.99452.47
– volume: 382
  start-page: 331
  issue: Part 1
  year: 2004
  ident: BF4001830_CR45
  publication-title: Biochem J
  doi: 10.1042/BJ20040469
– volume: 62
  start-page: 151
  issue: 3
  year: 2001
  ident: BF4001830_CR64
  publication-title: J Affect Disord
  doi: 10.1016/S0165-0327(99)00173-1
– volume: 338
  start-page: 21
  issue: 1
  year: 2003
  ident: BF4001830_CR65
  publication-title: Neurosci Lett
  doi: 10.1016/S0304-3940(02)01334-4
– volume: 11
  start-page: 241
  issue: 3
  year: 2006
  ident: BF4001830_CR44
  publication-title: Mol Psychiatry
  doi: 10.1038/sj.mp.4001758
– volume: 58
  start-page: 82
  issue: 1
  year: 2004
  ident: BF4001830_CR51
  publication-title: Psychiatry Clin Neurosci
  doi: 10.1111/j.1440-1819.2004.01197.x
– volume: 22
  start-page: 2718
  issue: 7
  year: 2002
  ident: BF4001830_CR17
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.22-07-02718.2002
– volume: 55
  start-page: 641
  issue: 5
  year: 2001
  ident: BF4001830_CR21
  publication-title: Brain Res Bull
  doi: 10.1016/S0361-9230(01)00522-6
– volume: 276
  start-page: 4020
  issue: 6
  year: 2001
  ident: BF4001830_CR47
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M006807200
– volume: 100
  start-page: 605
  issue: 2
  year: 2003
  ident: BF4001830_CR24
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.242716699
– volume: 359
  start-page: 490
  issue: 3
  year: 1995
  ident: BF4001830_CR32
  publication-title: J Comp Neurol
  doi: 10.1002/cne.903590310
– volume: 37
  start-page: 67
  issue: 2–3
  year: 1996
  ident: BF4001830_CR58
  publication-title: J Affect Disord
  doi: 10.1016/0165-0327(95)00050-X
– volume: 10
  start-page: 309
  issue: 3
  year: 2005
  ident: BF4001830_CR4
  publication-title: Mol Psychiatry
  doi: 10.1038/sj.mp.4001565
– volume: 199
  start-page: 103
  issue: 1–2
  year: 1999
  ident: BF4001830_CR80
  publication-title: Mol Cell Biochem
  doi: 10.1023/A:1006912010550
– volume: 110
  start-page: 216
  issue: 2
  year: 1987
  ident: BF4001830_CR25
  publication-title: J Pediatr
  doi: 10.1016/S0022-3476(87)80157-9
– volume: 35
  start-page: 171
  issue: 2
  year: 2003
  ident: BF4001830_CR66
  publication-title: Nat Genet
  doi: 10.1038/ng1235
– volume: 125
  start-page: 1428
  issue: Part 7
  year: 2002
  ident: BF4001830_CR15
  publication-title: Brain
  doi: 10.1093/brain/awf149
– volume: 57
  start-page: 525
  issue: 5
  year: 2005
  ident: BF4001830_CR57
  publication-title: Biol Psychiatry
  doi: 10.1016/j.biopsych.2004.11.041
– volume: 12
  start-page: 386
  issue: 4
  year: 2002
  ident: BF4001830_CR73
  publication-title: Cereb Cortex
  doi: 10.1093/cercor/12.4.386
– volume: 48
  start-page: 486
  issue: 6
  year: 2000
  ident: BF4001830_CR46
  publication-title: Biol Psychiatry
  doi: 10.1016/S0006-3223(00)00978-1
– volume: 14
  start-page: 241
  issue: 2
  year: 2005
  ident: BF4001830_CR10
  publication-title: Hum Mol Genet
  doi: 10.1093/hmg/ddi022
– volume: 9
  start-page: 406
  issue: 4
  year: 2004
  ident: BF4001830_CR22
  publication-title: Mol Psychiatry
  doi: 10.1038/sj.mp.4001437
– volume: 14
  start-page: 2995
  issue: 12
  year: 2003
  ident: BF4001830_CR49
  publication-title: J Am Soc Nephrol
  doi: 10.1097/01.ASN.0000095481.24091.C9
– volume: 55
  start-page: 41
  issue: 1
  year: 1994
  ident: BF4001830_CR52
  publication-title: Psychiatry Res
  doi: 10.1016/0925-4927(94)90010-8
– volume: 79
  start-page: 826
  issue: 4
  year: 2001
  ident: BF4001830_CR8
  publication-title: J Neurochem
  doi: 10.1046/j.1471-4159.2001.00628.x
– volume: 13
  start-page: 609
  issue: 6
  year: 2004
  ident: BF4001830_CR26
  publication-title: Hum Mol Genet
  doi: 10.1093/hmg/ddh065
– volume: 200
  start-page: 151
  issue: 3
  year: 1995
  ident: BF4001830_CR35
  publication-title: Neurosci Lett
  doi: 10.1016/0304-3940(95)12102-A
– volume: 4
  start-page: P3
  issue: 5
  year: 2003
  ident: BF4001830_CR41
  publication-title: Genome Biol
  doi: 10.1186/gb-2003-4-5-p3
– volume: 4
  start-page: 137
  issue: 2
  year: 2002
  ident: BF4001830_CR72
  publication-title: Bipolar Disord
  doi: 10.1034/j.1399-5618.2002.40201.x
SSID ssj0014765
Score 2.2676115
Snippet Mitochondrial defects in gene expression have been implicated in the pathophysiology of bipolar disorder and schizophrenia. We have now contrasted control...
SourceID pubmedcentral
proquest
gale
pubmed
pascalfrancis
crossref
springer
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 663
SubjectTerms Adult and adolescent clinical studies
Antidepressive Agents - pharmacology
Apoptosis
Apoptosis - genetics
Behavioral Sciences
Biological and medical sciences
Biological Psychology
Bipolar disorder
Bipolar Disorder - drug therapy
Bipolar Disorder - genetics
Bipolar Disorder - metabolism
Bipolar Disorder - pathology
Bipolar disorders
Brain
Brain - drug effects
Brain - metabolism
Brain - pathology
Cerebellum - drug effects
Cerebellum - metabolism
Cerebellum - pathology
Copy number
Death
Depression
Depressive Disorder - genetics
Depressive Disorder - metabolism
Depressive Disorder - pathology
DNA, Mitochondrial - genetics
DNA, Mitochondrial - metabolism
Emotional disorders
Female
Gene Dosage
Gene expression
Gene Expression Regulation - drug effects
Gene Expression Regulation - physiology
Gyrus Cinguli - drug effects
Gyrus Cinguli - metabolism
Gyrus Cinguli - pathology
Humans
Hydrogen-Ion Concentration
In Situ Hybridization
Lithium - pharmacology
Male
Medical sciences
Medicine
Medicine & Public Health
Mental disorders
Middle Aged
Mitochondria - drug effects
Mitochondria - metabolism
Mitochondrial DNA
Molecular Chaperones - biosynthesis
Molecular Chaperones - genetics
Mood
Mood disorders
Neoplasm Proteins - biosynthesis
Neoplasm Proteins - genetics
Nerve Tissue Proteins - biosynthesis
Nerve Tissue Proteins - genetics
Neurosciences
Oligonucleotide Array Sequence Analysis
original-article
Oxidative Stress - genetics
pH effects
Pharmacotherapy
Polymerase Chain Reaction
Postmortem Changes
Prefrontal Cortex - drug effects
Prefrontal Cortex - metabolism
Prefrontal Cortex - pathology
Proteasome Endopeptidase Complex - metabolism
Proteasomes
Psychiatry
Psychology. Psychoanalysis. Psychiatry
Psychopathology. Psychiatry
RNA, Messenger - biosynthesis
RNA, Messenger - genetics
Schizophrenia
Selective Serotonin Reuptake Inhibitors - pharmacology
Time Factors
Title Mitochondrial-related gene expression changes are sensitive to agonal-pH state: implications for brain disorders
URI https://link.springer.com/article/10.1038/sj.mp.4001830
https://www.ncbi.nlm.nih.gov/pubmed/16636682
https://www.proquest.com/docview/221254851
https://www.proquest.com/docview/2645752187
https://www.proquest.com/docview/68579896
https://www.proquest.com/docview/759318577
https://pubmed.ncbi.nlm.nih.gov/PMC3098558
Volume 11
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fb9MwELZgExLShPhN2Ch-QPBCtjTxT17QQJsqpE0IMalvke04YxNLs6WT4L_nznHbBTr66pPjOt-dP8ef7wh5Y53mSsMmB9YHmzIDnm6y2qRS5xbYCbhfEGMeHYvJCfsy5dOozemirHIRE0OgrmYOv5Hv5RBjgV3z8cf2MsWiUXi4Gito3CWbIXMZwFlOl_utMZOhkuS44HjYqVhMsZkVaq87371odxmWpEP9840lKQbmrdZ0MEl1X91iHf38V0X511FqWKEOH5IHkVrS_R4Lj8gd3zwm9_pik7-fkPYInBeCXVMh5tJwicVXFADkqf8V9bAN7W8Cd9Rcedqhuh3jIZ3PqDlF0p62ExouIX2gZzfE6BS4L7VYboJWMZ9n95ScHB58_zxJY72F1AHtmKdeOlFlFVMVE8ZVWpo8sxUm_FKMOaczw6WRtQgV03PvgapxYaW1RubWw472GdloZo1_QWhtZcFcBh0ayeBnsqLyRZ0X3CtTGJ6Q94spL11MRo41MX6W4VC8UGV3Xl60ZXxDCXm7NG_7LBy3Gb7D91eid0J_zsRLBjAqzHNV7o-V4kxoDpY7A0vwKjdoHg0QsHosBDRRCJ2Q7QUkyuj2XbkEKfS-plUwIMfAqWRCXi-b8cEodGv87LorheJSKy0SQm-xkFzjjXcJnTzvAbgaG9BHIVSeEDmA5tIAc4kPW5qzHyGneJFpxbmC-VuAeDXutTP98r__f5vc779Voa55h2zMr679K2BvczsKPjoim58Ojr9--wM4GEZ3
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3rT9RAEN-QI0YTYnxbQdgPPr5Y6LX7NDEGFXIIdzEGEr4tu-0eQqRX6RHlj_J_dKaPO04Pv9GvM9lud2Z-O9udByEvXKq50nDIgf3BhcyCpdtoaEOpYwfeCZhfFYzZH4jeAft8yA8XyO82FwbDKltMrIA6G6X4j3wjBowF75p33xc_QmwahZerbQeNWit2_eVPOLGV73Y-gXhfxvH21v7HXtg0FQhT2FvHoZepyKKMqYwJm2Za2jhyGVa1UoylqY4sl1YORdUWPPYe_BEunHTOyth5jnUOAPEXGSa0dsjih63Bl6-Tawsmq96VXSCGDM5OTVHPKFEb5en6WbHOsAkeRlxf2QSbrWCpsCWIZVj305jn8P4bt_nX5W21J27fI3cbZ5Zu1tp3nyz4_AG5Vbe3vHxIij7ABcBrnqGWh1XajM8oqKyn_lcTgZvTOve4pPbc0xLj6RGB6XhE7TEeE8KiR6u0p7f05Er4OwVvmzpscEGzpoJo-Ygc3IgwHpNOPsr9U0KHTiYsjWBAKxk8NkoynwzjhHtlE8sD8qZdcpM25c-xC8d3U13DJ8qUp-asMI2EAvJqwl7UdT-uY3yN8jOIBzBeapu0BpgVVtYym12lOBOaA-fKDCfYcTpDXp3RgOlrAUJFInRAlluVMA3QlGZiFjD6HKpg4I6DFycDsjYh44sxtC73o4vSCMWlVloEhF7DIbnGHHsJgzypFXA6N3BYhVBxQOSMak4YsHr5LCU_-VZVMU8irThXsH6tEk_nPXeln_33-9fI7d5-f8_s7Qx2l8md-k8ZRlWvkM74_MI_B99x7FYbi6Xk6KZB4g8pn4L-
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELaqIhASQrwJLa0PPC6km43fSAhVlNWW0ooDlfYWnMSBVjQbmq2gP41_x0ziZLuw5dZcPXIce-bz53gehDxLMyO0gUMO7A9pyC1Yuo0KGyoTp8BOwPwaZ8z9Azk-5B8mYrJCfnexMOhW2WFiA9T5NMN_5IMYMBbYtRgOCu8V8Wln9Lb6EWIBKbxo7apptBqy585_wumtfrO7A0v9PI5H7z-_G4e-wECYwT47C53KZB7lXOdc2iw3ysZRmmOGK815lpnICmVVIZsS4bFzwE2ETFWaWhWnTmDOA0D_a4oBqQJTUpP-rDfkqqliOWQCL1o19-k9I6YH9fHWSbXFsRwe-l5f2A79pnCrsjUsUNFW1lhGff_14PzrGrfZHUd3yG1Pa-l2q4d3yYor75HrbaHL8_uk2gfgAKAtc9T3sAmgcTkF5XXU_fK-uCVto5Brak8drdGzHrGYzqbUfsUDQ1iNaRMA9ZoeXXCEp8C7aYqlLmjuc4nWD8jhlSzFQ7JaTkv3mNAiVYxnEXRoFYfHRix3rIiZcNoyKwLyqpvyJPOJ0LEex_ekuZBnOqmPk5Mq8SsUkBe9eNVmALlM8CWuX4LIAP1l1gc4wKgwx1ayPdRacGkESK4vSIJFZwvNGwsaMH8tgKlk0gRkrVOJxENOnfQGAr0vaZUciDnwORWQzb4ZX4xOdqWbntWJ1EIZbWRA6CUSShiMtlfQyaNWAedjA-oqpY4DohZUsxfAPOaLLeXRtyafOYuMFkLD_HVKPB_30pl-8t_v3yQ3ABqSj7sHe2vkZvvLDN2r18nq7PTMPQUSOUs3GnOl5MtV48MfiwaFxQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Mitochondrial-related+gene+expression+changes+are+sensitive+to+agonal-pH+state%3A+implications+for+brain+disorders&rft.jtitle=Molecular+psychiatry&rft.au=Vawter%2C+M+P&rft.au=Tomita%2C+H&rft.au=Meng%2C+F&rft.au=Bolstad%2C+B&rft.date=2006-07-01&rft.pub=Nature+Publishing+Group&rft.issn=1359-4184&rft.volume=11&rft.issue=7&rft.spage=663&rft_id=info:doi/10.1038%2Fsj.mp.4001830&rft.externalDocID=A188546950
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1359-4184&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1359-4184&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1359-4184&client=summon